Mitochondrial genome engineering coming-of-age

Trends Genet. 2022 Aug;38(8):869-880. doi: 10.1016/j.tig.2022.04.011. Epub 2022 May 19.

Abstract

The mitochondrial genome has been difficult to manipulate because it is shielded by the organelle double membranes, preventing efficient nucleic acid entry. Moreover, mitochondrial DNA (mtDNA) recombination is not a robust system in most species. This limitation has forced investigators to rely on naturally occurring alterations to study both mitochondrial function and pathobiology. Because most pathogenic mtDNA mutations are heteroplasmic, the development of specific nucleases has allowed us to selectively eliminate mutant species. Several 'protein only' gene-editing platforms have been successfully used for this purpose. More recently, a DNA double-strand cytidine deaminase has been identified and adapted to edit mtDNA. This enzyme was also used as a component to adapt a DNA single-strand deoxyadenosine deaminase to mtDNA editing. These are major advances in our ability to precisely alter the mtDNA in animal cells.

Keywords: TALEN; gene editing; genetic engineering; mitochondria.

Publication types

  • Review

MeSH terms

  • Animals
  • DNA, Mitochondrial / genetics
  • Gene Editing
  • Genome, Mitochondrial* / genetics
  • Mitochondria / genetics

Substances

  • DNA, Mitochondrial